At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Apr 22, 2026 at 16:15 ET
Sutro Biopharma is holding its annual shareholder meeting to elect directors, ratify auditors, and approve executive compensation. This is a routine corporate governance filing with no material financial or strategic changes.
- Sutro Biopharma is holding its annual shareholder meeting on June 5, 2026
- Shareholders will vote on the election of Class II directors (Jane Chung, Connie Matsui, James Panek)
- Shareholders will vote to ratify Ernst & Young LLP as the independent auditor
- Shareholders will vote on a non-binding advisory vote on executive compensation
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access